Skip to content

Changing treatment of patients with a recurrent depressive disordered from cognitive behavioral therapy to acceptance and commitment therapy after early non-response to treatment

Changing treatment of patients with a recurrent depressive disordered from cognitive behavioral therapy to acceptance and commitment therapy after early non-response to treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21689
Enrollment
36
Registered
2020-12-22
Start date
2021-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent major depressive disorder

Interventions

All participants will receive five sessions of CBT in treatment phase 1 based on a manual by Bockting, Van Rijsbergen & Huibers (2017). In treatment phase 2, the CBT-group will continue with CBT from

Sponsors

HSK-groep
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants will be selected from patients, aged between 18 and 70 years, referred by their general practitioner to mental health care organization HSK-groep. During the first diagnostic assessment we will screen patients for criteria of a recurrent depressive disorder. Only patients who have a total score of 11 or higher on the Quick inventory of Depressive Symptomatology – Self Report (QIDS-SR), indicating at least a moderate level of depressive symptoms, are admitted to this study. Use of anti-depressive medication is allowed as long as patients do not change medication or dose.

Exclusion criteria

Exclusion criteria: Exclusion criteria for the study are a high risk of psychosis or suicide, organic brain syndrome, severe substance-abuse, borderline or antisocial personality disorder, inability for patients to focus sufficiently on their treatment, inability for patients to fill out questionnaires or having other problems taking precedence over their depression.

Design outcomes

Primary

MeasureTime frame
Total outcome scores on the QIDS-SR (depressive symptoms questionnaire), compared between groups

Secondary

MeasureTime frame
Total outcome scores on the MHC-SF (positive mental health questionnaire), compared between groups

Contacts

Public ContactMatthijs Wolters

HSK

m.wolters@hsk.nl0031620557890

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)